Top brand choice
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
HANZEMA (alitretinoin) is indicated for the treatment of severe chronic hand eczema refractory to high potency topical corticosteroids in adults.
Females must not become pregnant while taking HANZEMA and for at least one month after its discontinuation. HANZEMA can cause severe birth defects in infants born to women who become pregnant during treatment with HANZEMA in any amount, even for a short period of time. Potentially any exposed fetus can be affected. There are no accurate means of determining whether an exposed fetus has been affected (see WARNINGS AND PRECAUTIONS: Special populations, Women of child bearing potential). If pregnancy does occur during treatment with HANZEMA or within one month after its discontinuation, HANZEMA treatment must be immediately stopped and a physician and the patient should discuss the desirability of continuing the pregnancy. HANZEMA should only be prescribed by physicians knowledgeable in the use of systemic retinoids, who have full understanding of the risks of systemic retinoid therapy and the monitoring requirements (see INDICATIONS AND CLINICAL USE)